This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Koninklijke Philips, Dropbox, Cardinal Health, Enphase Energy and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Koninklijke Philips, Dropbox, Cardinal Health, Enphase Energy and Chemed
Large Caps Fight Coronavirus Under Defense Production Act
by Ritujay Ghosh
The Defense Production Act allows government to compel companies into manufacturing supplies for national defense purposes. 3M Company (MMM) has already responded to the situation.
Trading a Record "Cannonball Run" Global Week Ahead
by John Blank
The choice for stock pickers looks bifurcated. Very short term? Play "the Cannonball Run" regime. That means buy defensive names, and/or steer clear of stocks altogether.
5 Top Tech Stocks Rallying Over 20% Amid Coronavirus Crisis
by Nalak Das
A closer look into the technology sector reveals that a few stocks from this sector have actually skyrocketed in the past month defying coronavirus-induced mayhem.
U.S. Economy Likely to Reopen in May: 5 Top Growth Picks
by Nalak Das
Although the death toll continues to go up in the United States, the curves related to hospitalization, intensive-care check-ins and intubations are gradually flattening.
5 Must-Buy Electronics Stocks to Beat Coronavirus Woes
by Radhika Pujara
Investors can bet on SMTC Corporation (SMTX) and four other strong buy Electronics stocks that have strong fundamentals for a winning portfolio despite coronavirus concerns.
PHG or GRMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PHG vs. GRMN: Which Stock Is the Better Value Option?
Market to Stay Northbound Despite Volatility: 5 Growth Picks
by Nalak Das
Although, short-term fluctuations will continue on account of the coronavirus-induced crisis, overall market movement will remain positively sloped.
New Strong Buy Stocks for April 2nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Ventilator Stocks Next Big Thing in Coronavirus-Hit Market?
by Urmimala Biswas
Tesla's Elon Musk holds discussion regarding ventilators production with Medtronic, likely to set foot in the ventilator-manufacturing space.
Koninklijke Philips' (PHG) Q4 Earnings & Sales Rise Y/Y
by Zacks Equity Research
Koninklijke Philips' (PHG) fourth-quarter results reflect robust performance in the Diagnosis & Treatment business despite negative impact from tariffs.
COPD Devices Gain Regulatory Go-Ahead: 3 Stocks in Focus
by Sriparna Ghosal
Growth in the COPD devices market can be attributed to factors like steadily rising geriatric population, increasing incidence of smoking and chronic respiratory diseases.
Philips Inks Partnerships to Reduce Mortality Rates in Congo
by Zacks Equity Research
Philips (PHG) partners with UNFPA and the Congo government to reduce maternal and newborn mortality rate in the country.
PHG vs. GRMN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PHG vs. GRMN: Which Stock Is the Better Value Option?
Philips' New Digital Health Solutions Expand Portfolio
by Zacks Equity Research
Philips (PHG) announces new consumer focused digital health solutions to strengthen healthcare portfolio.
Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Eli Lilly (LLY) and PNC Financial (PNC).
Philips Partners With RMC to Innovate Imaging Solutions
by Zacks Equity Research
Philips (PHG) inks partnership with Regional Medical Centre to drive innovation and expand its market share in the healthcare sector.
Philips' New Imaging Solution Expands Healthcare Portfolio
by Zacks Equity Research
Philips (PHG) expands footprint in the health tech space with the introduction of next- generation imaging solution.
Koninklijke Philips' (PHG) Q3 Earnings & Sales Rise Y/Y
by Zacks Equity Research
Koninklijke Philips' (PHG) third-quarter results reflect robust performance in the Diagnosis & Treatment business despite negative impact from tariffs.
Philips Boosts Stellarex Portfolio, Expands in Healthcare
by Zacks Equity Research
Phillips (PHG) bolsters presence in Diagnosis & Treatment business with new low-dose drug-coated balloons.
Philips & Spencer Health to Extend Joint Solution to Europe
by Zacks Equity Research
Philips (PHG) and Spencer's joint digital solution, which improves medication adherence in patients in the United States, is set to hit select European markets.
Vishay Expands Passive Component Offerings With New Resistors
by Zacks Equity Research
Vishay Intertechnology (VSH) launches WFPA3939 and WFPB3939 resistors, which are likely to drive momentum across automotive, industrial and AMS applications.
Tech Taking Personal Healthcare by Storm: Stocks in Focus
by Zacks Equity Research
Personal healthcare market is booming on expanding initiatives by tech giants like Apple (AAPL), Fitbit (FIT) and Alphabet (GOOGL), to name a few.
Trimble's Latest Module to Expand Fleet Management Presence
by Zacks Equity Research
Trimble (TRMB) launched Contract Maintenance module, which is likely to aid its momentum across fleets, outsourced maintenance providers and leasing companies.
Top Ranked Growth Stocks to Buy for August 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 21st